Miv Therapeutics, Inc. (IVT) Tops Q1 EPS by 7c

Miv Therapeutics, Inc. (NYSE: IVT) reported Q1 EPS of $0.04, $0.07 better than the analyst estimate of ($0.03).

For earnings history and earnings-related data on Miv Therapeutics, Inc. (IVT) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• UBS says bull market has further to run
• The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue